Please assess the completion status of the following clinical trial:

Trial Title: A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Must have understood and voluntarily signed the informed consent and privacy form.~2. Age ≥ 18 years at the time of signing the informed consent and privacy form.~3. Patients with available hospital medical chart since the start of apremilast treatment ('index date').~4. Diagnosis of plaque psoriasis.~5. Treatment with apremilast for plaque psoriasis, according to Summary of Product Characteristics (SmPC), started 6 (±1) months before enrollment. Patients who interrupted apremilast treatment before enrollment will also be included.~6. Ability to understand (read \& write) the Italian language and to follow the study instructions.~Exclusion Criteria:~1. Refusal to participate in this study or current participation in the treatment phase of an interventional clinical trial.~2. Started apremilast as part of a clinical trial, or previous apremilast use (prior to the index date).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).